Stressors impair immune defenses and pose risks among cancer patients. Natural Killer cells are not the sole immune defense against tumor development. Utilizing an NK-sensitive tumor model, this study evaluated immune effects to stress and determined whether lung metastasis resulted from B cells' inability to augment tumorlytic function. Lung metastasis directly correlated with delayed lung B cell accumulation compared to NK, and T cells. Decreased interleukin-12 cytokine and CD80 + molecule expression by B cells correlated with decreased tumor lysis and increased tumor development. Thus, tumor defenses in the lung given stress exposure can depend on the B cell function.
Introduction
The metastatic potential of most tumors depends on their ability to escape the recognition and destruction by circulating and resident immune cell populations (Leber and Efferth, 2009; Teng et al., 2008) . Stressors that impair the host immune defense system are believed to pose formidable risks among cancer patients, allowing for increase tumor spread and susceptibility to infectious disease (Giordano et al., 2007; Goossen et al., 2007; Mazza, 2010; Wong A et al., 2010) . Physical stressors such as surgery, chemotherapy and radiation have previously been shown to diminish the function of immune effector cells in cancer patients (Lissoni et al., 2009; Eyrich et al., 2009; Vallejo et al., 2003; Andersen et al., 1998) . Also, a large body of evidence suggests that psychological stress (e.g. depression, anxiety) associated with cancer diagnosis and therapies account for impaired immune status (Goodkin et al., 1995; McGregor and Antoni, 2009; Nelson et al., 2008; Steel et al., 2004) . Experimental animal models of stress and tumor development have substantiated such findings by demonstrating diverse effects of stress on tumor-immune defenses (Vegas et al., 2006; Azpiroz et al., 2008) . Such studies have spawned a growing interest in the field of psychoneuroimmunology (PNI) research, with the anticipated discovery of multidisciplinary therapies against cancer and other diseases.
Abrogation of natural killer cell function has been the primary focus of stress-induced immune suppression, resulting in cancer susceptibility. As early as 1978, Holden et al., discovered that stressors could increase tumor growth in experimental animals, suppressing lymphoid proliferation and NK cell activity in vitro (Holden, 1978) . Subsequently, numerous human and animal studies highlighted the effect of stressors on NK cells and their association with tumor progression in vivo (Kanno et al., 1997; Staurenghi et al., 1997) . In recent years, attempts have been made to identify cellular and molecular mechanisms involved in NK suppression. For example, cancer-related stress was found to correlate with decreased NK cell toxicity (Witek-Janusek et al., 2007; Qiu et al., 2003; Lang et al., 2006; Naliboff et al., 1995) . Neuroendocrine mediators derived from activation of the central nervous system such as corticosteroids, catecholamines and opioids are found to impact NK cell function (Staurenghi et al., 1997) . Most recently, stress effects on NKassociated alterations on receptor-mediated activation and intracellular signaling pathways have been considered molecular targets, possibly explaining NK cell dysfunction (Kimura et al., 2008; Oya et al., 2000; Varker et al., 2007) .
NK cells are not the sole immune defense mechanism against tumor development, but instead require optimal collaboration with other host immune constituents. Notably is the complementary role of tumorspecific cytotoxic responses of CD8 + T cells (Cuff et al., 2010) . In addition, dendritic cell-mediated tumor presentation plays an important role in directing tumor-specific adaptive T cell and humoral antibody responses (Chaux, 1995; Dumitriu et al., 2009; Lapteva et al., 2009 
